Acquirer(s)
- Symbion Health Limited
Target(s)
- Nexus Pathology
Summary
Symbion Health Limited has acquired the non-histopathology assets of Nexus Pathology.Market definition
The ACCC considered the completed acquisition in the context of the market for community pathology services in Queensland.Competition analysis
The ACCC formed the view that the completed acquisition was unlikely to substantially lessen competition in the relevant market due to the small increase in Symbion's market share and the existence of a number of competing suppliers which would continue to constrain the merged firm.Timeline
| Date | Event |
|---|---|
The acquisition was completed. |
|
ACCC commenced review under the Merger Review Process Guidelines. |
|
Closing date for submissions from interested parties. |
|
ACCC announced it would not oppose the completed acquisition. |